Nature of Business and Liquidity (Details) |
6 Months Ended |
---|---|
Jun. 30, 2019
clinicalTrial
candidate
drug
project
technology
| |
Product Information | |
Number of core drug technologies | technology | 3 |
Number of drug candidates | candidate | 6 |
Number of drugs in clinical trials | drug | 3 |
Number of clinical trials | clinicalTrial | 4 |
Number of other drug development projects | project | 5 |
Food and Drug Administration | |
Product Information | |
Market exclusivity extension period (years) | 5 years |
European Union | |
Product Information | |
Market exclusivity extension period (years) | 10 years |
Animal Life Science | |
Product Information | |
Ownership interest (percent) | 10.00% |